Topic: Multiple Sclerosis
The US Food and Drug Administration (FDA) has approved a drug which has been found to allow with multiple sclerosis (MS) to walk faster, the drug watchdog said. Multiple sclerosis patients treated with the drug, Ampyra - generic name dalfampridine - were found in clinical trials to have faster walking speeds than those treated with a placebo, the FDA said. "Trouble with ...
The Food and Drug Administration (FDA) has approved a drug which has been found to allow with multiple sclerosis (MS) to walk faster, the drug watchdog said. Multiple sclerosis patients treated with the drug, Ampyra - generic name dalfampridine - were found in clinical trials to have faster walking speeds than those treated with a placebo, the FDA said. "Trouble with walking ...
Multiple sclerosis is a difficult disorder of the nervous system which can generate a broad range of symptoms varying in intensity and duration. Each patient?s feel with multiple sclerosis is different and symptoms are perceived differently from someone to another. Multiple sclerosis can involve visual, sensory and motor symptoms, depending on the body systems which are affected by the ...
Tests of the first two oral drugs developed for treating multiple sclerosis show that both cut the frequency of relapses and may slow progression of the disease, but with side effects that could pose a tough decision for patients. Two experts not involved in the studies said the ...
